Upload
tia
View
41
Download
0
Tags:
Embed Size (px)
DESCRIPTION
IMPROVING THE USE OF ARTEMISININ-BASED COMBINATION THERAPY IN RURAL ZAMBIA. Kojo Yeboah-Antwi Centre for Global Health and Development Boston University. Third International Conference for Improving Use of Medicines Antalya, Turkey November 15, 2011. Background . - PowerPoint PPT Presentation
Citation preview
IMPROVING THE USE OF ARTEMISININ-BASED
COMBINATION THERAPY IN RURAL ZAMBIA
Third International Conference for Improving Use of MedicinesAntalya, Turkey
November 15, 2011
Kojo Yeboah-AntwiCentre for Global Health and Development
Boston University
Background • Many sick children in rural Zambia are seen by
community health workers (CHW) because public health facility-based services are not readily accessible
• Zambia has changed first line drug for uncomplicated malaria to more expensive and effective artemisinin-based combination therapies (ACTs)
• Relatively little known about how to optimally deploy ACTs to the community level
• Concerns about potential overuse of ACTs and development of resistance if use by CHWs is not guided by rapid diagnostic tests (RDTs)
Overall Study Goal
Demonstrate the effectiveness and feasibility of using CHWs to manage malaria (with artemether-lumefantrine) guided by RDTs
Objectives Will RDT use lead to reduction of overuse of
ACTs?
How well will CHWs follow a treatment algorithm and adhere to results of the RDTs?
Will children and CHWs experience any side effects with the pricking?
What happens to children with RDT negative results who do not receive ACTs?
Will the community accept CHWs performing RDTs and prescribing ACTs?
Study Location Southern Province of
Zambia Mazabuka and
Siavonga districts Chikankata Mission
Hospital area Population: 70,000 1 Mission Hospital
and 5 Rural Health Centers
Study Sites
Chaanga RHC
Mwanamunzya CHP
Hamukombwe CHP
Study Design Cluster randomized, controlled trial
around community health posts manned by CHWs
Community health posts matched according to distance from rural health center
Intervention Both intervention and control CHWs trained in
classification and treatment of febrile illness
Both CHWs supplied with ACTs and antipyretics
Intervention CHWs received additional training on RDTs and infection control
Intervention CHWs received RDTs and supplies for waste disposal and infection control
Enrolment Children aged 6 mo to 5 yrs with fever were
enrolled
Children with severe illness excluded and referred
History, examination, RDT (in intervention arm), classification and treatment
Baseline form completed (findings, results, treatment, address)
Follow-up Patients seen at day 5-7 to collect information on
visit, outcome of treatment, additional care received
Determine current condition and advise as necessary
Monthly data from CHPs on patient seen, supplies and referrals
Post intervention FGDs and IDIs of caregivers, CHWs, health workers and community leaders
Baseline Characteristics of CHWs
Intervention (n=18) Control (n=19)
Male 83.3% 89.5%Age in years: Mean (range)
40.3 (26-53) 40.0 (27-55)
Education: Secondary 72.2% 64.4%Considered as full time 5.6% 26.3%Years of practice: Mean (range)
10.2 (1-26) 7.3 (1-22)
Trained by Chikankata 55.6% 63.2%Last Refresher Course: less than a year
55.6% 52.6%
Supervision By RHC in last 3 months
44.4% 42.1%
Distance of CHP from RHC: Mean (range) km
9.2 (1-15) 9.3 (3-15)
Baseline Participant CharacteristicsCharacteristics Intervention
(n=1017)Control
(n=2108)Sex (female) (%) 47.6% 48.8%Age (mean) (SD) months 22.6 (14.0) 23.6 (14.7)Children underweight (WAZ score <-2.00)
28.1% 30.3%
Mother’s Education:No formal education 45.4% 37.7%
Primary 45.5% 54.2%Mother’s occupation:
Farmer 58.1% 48.9%Housewife 36.5% 46.4%
Households with 6 or fewer persons
64.2% 62.6%
Immunizations up to date 59.5% 67.5%Slept under ITN last night 71.3% 69.5%
Results
Intervention Control RR (95% CI)
Correct Classification1
99.7% 98.9% 1.01 (1.00 – 1.01)
Appropriate treatment2
98.2% 99.3% 0.99 (0.97 – 1.00)
Febrile children receiving ACTs
27.5% 99.1% 0.23 (0.14 – 0.38)
1Intervention: classify as malaria if RDT (+), and not malaria if RDT (-)Control: classify as malaria if fever (+), and no malaria if fever (-)
2Prescribe ACT if classified as malaria; ACT not prescribed if classified as not malaria
Results 975 RDTs done of which 271 (27.8%) were positive and 704
were negative
3 of 704 RDT negatives received ACTs from CHWs
4 of 271 RDT positives did not receive ACT from the CHWs
5 of the RDT negatives who did not receive ACTs from CHWs were not satisfied and managed to get ACTs from other sources
91.2% of the RDT negatives got well with only antipyretics and needed no additional treatment
Adverse Effects with RDT
Of 975 RDTs done: 3 children with minor bruises
2 children with skin infection
14 children with minor bleeding
1 incident of self prick
Community Acceptance
Caregivers were comfortable with CHWs pricking children to test for malaria
Caregivers trusted results of the RDTs
CHWs felt confident in performing RDTs and treating with ACTs
Health workers endorse CHWs use of RDTs and ACTs Community leaders happy with intervention and want
expansion to other areas and adults
Conclusions CHWs are capable of performing RDTs and appropriately
dispensing ACTs
Use of RDTs and ACTs by CHW is safe and effective
Use of RDTs at the community level by CHWs has potential to reduce the overuse of ACTs and improve ACT use
Health workers see CHWs involvement in malaria treatment with RDTs and ACTs as positive and has the potential to reduce workload at health facilities
Community acceptance of malaria treatment by CHWs is overwhelmingly encouraging
Limitations More CHP attendance in Control arm
resulted in relative imbalance between the two study arms
“full time” CHWs Varied cluster size No evidence of “contamination”
Recall bias
Designed not to repeat parasitological test at follow up
Study Team Kojo Yeboah-Antwi Portipher Pilingana Kazungu Siazelee William B. MacLeod Katherine Semrau Penelope Kalesha Busiku Hamainza Donald Thea
Davidson H. Hamer Lora L. Sabin Karen Kamholz Euphasia Mtonga Pascalina Chanda Arthur Mazimba Phil Seidenberg
Funding USAID/Washington through CFAR
Cooperative Agreement GHSA-00-00020 with BU
President’s Malaria Initiative (Washington DC)